Position in ABBV
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$24,187,133
+$3,908,148 QoQ
Shares Held
96,118
+3.1% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#548
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prospera Financial Services Inc holds $193,149,306 across 14 Drug Manufacturers - General names. ABBV ranks #3 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
46,944 | $56,306,046 | |
| 2 | JNJ |
Johnson & Johnson
|
174,910 | $44,421,892 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
96,118 | $24,187,133 | |
| 4 | NVO |
Novo Nordisk A S
|
308,903 | $14,808,809 | |
| 5 | MRK |
Merck & Co., Inc.
|
102,060 | $13,114,710 | |
| 6 | AZN |
Astrazeneca PLC
|
56,268 | $10,669,538 | |
| 7 | AMGN |
Amgen Inc
|
26,804 | $9,706,264 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
71,841 | $9,076,391 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,187,133 | 96,118 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $20,278,985 | 93,241 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $20,549,248 | 89,935 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $21,631,392 | 93,424 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $16,554,705 | 89,186 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $18,999,692 | 90,682 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $13,974,861 | 78,643 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $14,327,963 | 72,554 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $12,323,368 | 71,848 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $12,161,730 | 66,786 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $9,292,621 | 59,964 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,479,576 | 56,887 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,642,963 | 56,728 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $7,665,059 | 48,096 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,534,258 | 46,620 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $4,965,501 | 36,998 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $4,509,796 | 29,445 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $5,070,314 | 31,277 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $12,385,715 | 91,475 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $9,380,914 | 86,965 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,178,808 | 81,488 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $2,816,641 | 26,027 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,574,600 | 24,028 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $15,591 | 178 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $2,607,955 | 26,563 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,664,980 | 21,853 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||